Teriparatide Induced Delayed Persistent Hypercalcemia [PDF]
Case Reports in Endocrinology, 2014 Teriparatide, a recombinant PTH, is an anabolic treatment for osteoporosis that increases bone density. Transient hypercalcemia is a reported side effect of teriparatide that is seen few hours following administration of teriparatide and resolves usually
Nirosshan Thiruchelvam +3 more
doaj +2 more sources
Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide [PDF]
JBMR Plus, 2019 Teriparatide, currently only available in brand form in the United States, is a costly drug approved for the treatment of postmenopausal osteoporotic women who are at high risk of fracture.
Takahiro Mori +2 more
doaj +2 more sources
Clinical Interventions in Aging, 2017 Chunyan Lu,1 Yun Chen,2 Bin Zhang,2 Yu Chen,2 Fan Bai,2 Decai Chen1 1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China; 2Lilly Suzhou Pharmaceutical Co.
Lu C +5 more
doaj +1 more source
Clinical Medicine Insights: Endocrinology and Diabetes, 2012 Bone fractures are one of the leading causes of emergency room visits worldwide, with approximately 8 million bony fractures occurring annually in the US alone. Although the majority of fractures do not cause significant long-term morbidity and mortality,
Pooja Raghavan, Elena Christofides
doaj +2 more sources
São Paulo Medical JournalCONTEXT AND OBJECTIVE: Osteoporosis is defined as a disease characterized by low bone mass and deterioration of the bone tissue microarchitecture. Teriparatide stimulates the formation and action of osteoblasts, which are responsible for bone formation ...
Virgínia Fernandes Moça Trevisani +4 more
doaj +2 more sources
Clinical Interventions in Aging, 2015 Takanori Yamamoto,1 Mika Tsujimoto,2 Hideaki Sowa11Medical Science, Lilly Research Laboratories, Medicines Development Unit Japan, 2Asia Pacific Statistical Science-Japan, Science and Regulatory Affairs, LRL MDU-Japan, Eli Lilly Japan K.K, Kobe, Hyogo ...
Yamamoto T, Tsujimoto M, Sowa H
doaj +1 more source
Bilateral healing of pseudofractures in hypophosphatasia with teriparatide: a case report [PDF]
Journal of Medical Case ReportsBackground Hypophosphatasia is a rare, inherited metabolic bone disease characterized by impaired activity of tissue-nonspecific alkaline phosphatase leading to pathological mineralization of hard tissue, predisposing to poorly healing fractures. Limited
Elaf Al-Saoudi +2 more
doaj +2 more sources
The Effect of Subcutaneous Teriparatide Treatment on Mobility, Back Pain, and Patient Satisfaction in Patients with Vertebral Osteoporotic Fractures: A Cross-Sectional Study with 36-Month Follow-up [PDF]
, 2023 Aim:Although the effectiveness of teriparatide on bone mineral density (BMD), fracture risk, and back pain in severe osteoporosis is known, no comprehensive study has been conducted in the Turkish population regarding its impact on mobility and patient ...
Sinan Bagcaci, Ramazan Yilmaz
core +1 more source
Suitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in a healthcare management areaSuitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in a healthcare management area DOI: 10.7399/fh.2016.40.4.9953 [PDF]
Farmacia Hospitalaria, 2016 Objective: To analyse the suitability of teriparatide prescriptions for osteoporosis treatment in a health management area, as well as the level of acceptance of pharmacotherapeutic recommendations made to physicians. Design: A prospective interventional
Maria Rosa Cantudo-Cuenca +5 more
doaj +1 more source
Acta Orthopaedica, 2018 Background and purpose — Teriparatide accelerates fracture healing in animals and probably in man. Abaloparatide is a new drug with similar although not identical effects on the teriparatide receptor.
Magnus Bernhardsson, Per Aspenberg
doaj +1 more source